Common Stock SEC Reporting - Current
Verified Company Profile 7/14/2016
Contact Info
  • co Shandong Spring Pharmaceutical Co.
  • Economic Development Zone
  • Gucheng Road, Sishui County
  • Shandong Province 373200
  • China

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000847464
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: FL, USA
Year of Inc. 1989
Employees 279 a/o Mar 31, 2016
Company Officers/Contacts
Yan Tinghe CEO
Maogang Sun COO, Manufacturing Ops.
Li Chuanmin CFO
Zecheng Shao Vice President, IR
Company Directors
Yan Tinghe Chairman
Robert Fanella
Zhang Jirui
Zhang Wengao
Company Notes
  • Formerly=itLinkz Group, Inc. until 11-07
  • Formerly=Medical Technology & Innovations, Inc. until 4-07
  • Formerly=Southstar Productions, Inc. until 9-95
Service Providers
Accounting/Auditing Firm
Paritz & Company, P.A.
15 Warren St.
Suite 25
Hackensack, NJ, 07601
United States

Legal Counsel
McLaughlin & Stern, LLP
260 Madison Avenue
New York, NY, 10016
United States

Investor Relations Firm
Not Available
CYIG Security Details
Share Structure
Market Value1 $7,143,400 a/o Dec 02, 2016
Authorized Shares 100,000,000 a/o Jun 21, 2016
Outstanding Shares 29,764,168 a/o Nov 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,126,227 a/o Jun 21, 2016
Par Value No Par Value
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders of Record 768 a/o Jun 21, 2016
Short Selling Data
Short Interest 9,998 (100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security